US Stock MarketDetailed Quotes

VYGR Voyager Therapeutics

Watchlist

8.620
+0.220+2.62%

Trading Jun 3 10:54 ET

468.87MMarket Cap-50705P/E (TTM)

Voyager Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

-87.03%19.52M

511.16%250.01M

5,910.39%90.06M

-88.77%4.61M

581.60%4.85M

22,769.30%150.48M

9.33%40.91M

-105.52%-1.55M

2,672.33%41.09M

-47.53%712K

Operating revenue

-87.03%19.52M

511.16%250.01M

5,910.39%90.06M

-88.77%4.61M

581.60%4.85M

22,769.30%150.48M

9.33%40.91M

-105.52%-1.55M

2,672.33%41.09M

-47.53%712K

Cost of revenue

Gross profit

Operating expense

29.36%35.7M

39.51%127.99M

56.42%36M

28.06%34.12M

50.80%30.28M

25.39%27.6M

-17.37%91.74M

2.87%23.01M

0.06%26.64M

-32.94%20.08M

Selling and administrative expenses

-4.66%8.61M

15.63%35.82M

21.04%10.24M

13.01%8.26M

9.83%8.29M

17.87%9.03M

-16.82%30.98M

1.33%8.46M

-16.15%7.31M

-27.64%7.55M

-General and administrative expense

-4.66%8.61M

15.63%35.82M

21.04%10.24M

13.01%8.26M

9.83%8.29M

17.87%9.03M

-16.82%30.98M

1.33%8.46M

-16.15%7.31M

-27.64%7.55M

Research and development costs

45.91%27.09M

51.69%92.17M

77.01%25.76M

33.75%25.86M

75.50%21.99M

29.40%18.57M

-17.65%60.76M

3.79%14.55M

7.94%19.34M

-35.78%12.53M

Operating profit

-113.17%-16.18M

340.01%122.01M

320.10%54.06M

-304.31%-29.51M

-31.29%-25.43M

675.57%122.88M

30.94%-50.84M

-530.78%-24.56M

157.43%14.44M

32.25%-19.37M

Net non-operating interest income expense

161.11%4.87M

554.07%11.72M

223.16%3.15M

529.17%3.43M

1,394.98%3.27M

5,912.90%1.86M

559.49%1.79M

251.79%976K

350.41%545K

356.25%219K

Non-operating interest income

161.11%4.87M

----

529.17%3.43M

1,394.98%3.27M

5,912.90%1.86M

----

350.41%545K

356.25%219K

Total other finance cost

----

-554.07%-11.72M

----

-559.49%-1.79M

----

Other net income (expense)

-99.89%3K

-95.08%3K

-5.62%2.65M

-103.54%-23K

2,454.46%2.64M

103.85%61K

Other non- operating income (expenses)

----

-99.89%3K

--0

----

-95.08%3K

----

-5.62%2.65M

-103.54%-23K

2,454.46%2.64M

103.85%61K

Income before tax

-109.07%-11.32M

388.28%133.74M

342.34%57.22M

-247.97%-26.08M

-16.04%-22.15M

685.15%124.75M

34.84%-46.39M

-513.56%-23.61M

170.11%17.62M

36.63%-19.09M

Income tax

-98.01%14K

8,700.00%1.41M

5,037.50%822K

-177K

59K

704K

16K

Net income

-109.13%-11.33M

385.14%132.33M

338.70%56.4M

-246.96%-25.9M

-16.35%-22.21M

681.85%124.04M

34.82%-46.41M

-513.84%-23.63M

170.11%17.62M

36.63%-19.09M

Net income continuous Operations

-109.13%-11.33M

385.14%132.33M

338.70%56.4M

-246.96%-25.9M

-16.35%-22.21M

681.85%124.04M

34.82%-46.41M

-513.84%-23.63M

170.11%17.62M

36.63%-19.09M

Minority interest income

Net income attributable to the parent company

-109.13%-11.33M

385.14%132.33M

338.70%56.4M

-246.96%-25.9M

-16.35%-22.21M

681.85%124.04M

34.82%-46.41M

-513.84%-23.63M

170.11%17.62M

36.63%-19.09M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-109.13%-11.33M

385.14%132.33M

338.70%56.4M

-246.96%-25.9M

-16.35%-22.21M

681.85%124.04M

34.82%-46.41M

-513.84%-23.63M

170.11%17.62M

36.63%-19.09M

Basic earnings per share

-106.56%-0.2

354.55%3.08

301.64%1.23

-228.26%-0.59

-2.00%-0.51

644.64%3.05

35.98%-1.21

-506.67%-0.61

168.66%0.46

37.50%-0.5

Diluted earnings per share

-106.80%-0.2

345.45%2.97

295.08%1.19

-231.11%-0.59

-2.00%-0.51

625.00%2.94

35.98%-1.21

-506.67%-0.61

167.16%0.45

37.50%-0.5

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	-87.03%19.52M	511.16%250.01M	5,910.39%90.06M	-88.77%4.61M	581.60%4.85M	22,769.30%150.48M	9.33%40.91M	-105.52%-1.55M	2,672.33%41.09M	-47.53%712K
Operating revenue	-87.03%19.52M	511.16%250.01M	5,910.39%90.06M	-88.77%4.61M	581.60%4.85M	22,769.30%150.48M	9.33%40.91M	-105.52%-1.55M	2,672.33%41.09M	-47.53%712K
Cost of revenue
Gross profit
Operating expense	29.36%35.7M	39.51%127.99M	56.42%36M	28.06%34.12M	50.80%30.28M	25.39%27.6M	-17.37%91.74M	2.87%23.01M	0.06%26.64M	-32.94%20.08M
Selling and administrative expenses	-4.66%8.61M	15.63%35.82M	21.04%10.24M	13.01%8.26M	9.83%8.29M	17.87%9.03M	-16.82%30.98M	1.33%8.46M	-16.15%7.31M	-27.64%7.55M
-General and administrative expense	-4.66%8.61M	15.63%35.82M	21.04%10.24M	13.01%8.26M	9.83%8.29M	17.87%9.03M	-16.82%30.98M	1.33%8.46M	-16.15%7.31M	-27.64%7.55M
Research and development costs	45.91%27.09M	51.69%92.17M	77.01%25.76M	33.75%25.86M	75.50%21.99M	29.40%18.57M	-17.65%60.76M	3.79%14.55M	7.94%19.34M	-35.78%12.53M
Operating profit	-113.17%-16.18M	340.01%122.01M	320.10%54.06M	-304.31%-29.51M	-31.29%-25.43M	675.57%122.88M	30.94%-50.84M	-530.78%-24.56M	157.43%14.44M	32.25%-19.37M
Net non-operating interest income expense	161.11%4.87M	554.07%11.72M	223.16%3.15M	529.17%3.43M	1,394.98%3.27M	5,912.90%1.86M	559.49%1.79M	251.79%976K	350.41%545K	356.25%219K
Non-operating interest income	161.11%4.87M	----	----	529.17%3.43M	1,394.98%3.27M	5,912.90%1.86M	----	----	350.41%545K	356.25%219K
Total other finance cost	----	-554.07%-11.72M	----	----	----	----	-559.49%-1.79M	----	----	----
Other net income (expense)		-99.89%3K	0		-95.08%3K		-5.62%2.65M	-103.54%-23K	2,454.46%2.64M	103.85%61K
Other non- operating income (expenses)	----	-99.89%3K	--0	----	-95.08%3K	----	-5.62%2.65M	-103.54%-23K	2,454.46%2.64M	103.85%61K
Income before tax	-109.07%-11.32M	388.28%133.74M	342.34%57.22M	-247.97%-26.08M	-16.04%-22.15M	685.15%124.75M	34.84%-46.39M	-513.56%-23.61M	170.11%17.62M	36.63%-19.09M
Income tax	-98.01%14K	8,700.00%1.41M	5,037.50%822K	-177K	59K	704K	16K	16K	0	0
Net income	-109.13%-11.33M	385.14%132.33M	338.70%56.4M	-246.96%-25.9M	-16.35%-22.21M	681.85%124.04M	34.82%-46.41M	-513.84%-23.63M	170.11%17.62M	36.63%-19.09M
Net income continuous Operations	-109.13%-11.33M	385.14%132.33M	338.70%56.4M	-246.96%-25.9M	-16.35%-22.21M	681.85%124.04M	34.82%-46.41M	-513.84%-23.63M	170.11%17.62M	36.63%-19.09M
Minority interest income
Net income attributable to the parent company	-109.13%-11.33M	385.14%132.33M	338.70%56.4M	-246.96%-25.9M	-16.35%-22.21M	681.85%124.04M	34.82%-46.41M	-513.84%-23.63M	170.11%17.62M	36.63%-19.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-109.13%-11.33M	385.14%132.33M	338.70%56.4M	-246.96%-25.9M	-16.35%-22.21M	681.85%124.04M	34.82%-46.41M	-513.84%-23.63M	170.11%17.62M	36.63%-19.09M
Basic earnings per share	-106.56%-0.2	354.55%3.08	301.64%1.23	-228.26%-0.59	-2.00%-0.51	644.64%3.05	35.98%-1.21	-506.67%-0.61	168.66%0.46	37.50%-0.5
Diluted earnings per share	-106.80%-0.2	345.45%2.97	295.08%1.19	-231.11%-0.59	-2.00%-0.51	625.00%2.94	35.98%-1.21	-506.67%-0.61	167.16%0.45	37.50%-0.5
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall